{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T17:49:29Z","timestamp":1747244969151},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,29]]},"DOI":"10.7759\/cureus.28527","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T12:08:57Z","timestamp":1661774937000},"source":"Crossref","is-referenced-by-count":1,"title":["A Refractory Case of Amiodarone Thyrotoxicosis"],"prefix":"10.7759","author":[{"given":"Marta","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Paulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z\u00e9lia","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.29.5.571","article-title":"Adverse effects of long-term amiodarone therapy","volume":"29","author":"Park HS","year":"2014","unstructured":"Park HS, Kim YN. Adverse effects of long-term amiodarone therapy. Korean J Intern Med. 2014, 29:571-3. 10.3904\/kjim.2014.29.5.571","journal-title":"Korean J Intern Med"},{"key":"ref2","article-title":"Efeitos da amiodarona na tiroide. Aspectos actuais (in Portuguese)","volume":"17","author":"Campos MV","year":"2004","unstructured":"Campos MV. Efeitos da amiodarona na tiroide. Aspectos actuais (in Portuguese). Acta M\u00e9d Port. 2004, 17:241-6.","journal-title":"Acta M\u00e9d Port"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria S","year":"2005","unstructured":"Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005, 118:706-14. 10.1016\/j.amjmed.2004.11.028","journal-title":"Am J Med"},{"key":"ref4","article-title":"Amiodarone-induced thyroid dysfunction in clinical practice","volume":"10","author":"Ursella S","year":"2006","unstructured":"Ursella S, Tesla A, Mazzone M, Silveri NG. Amiodarone-induced thyroid dysfunction in clinical practice. Eur Rev Med Pharmacol Sci. 2006, 10:269-78.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.36660\/abc.20190757","article-title":"Amiodarone-induced thyrotoxicosis - literature review & clinical update","volume":"117","author":"Souza LV","year":"2021","unstructured":"Souza LV, Campagnolo MT, Martins LC, Scanavacca MI. Amiodarone-induced thyrotoxicosis - literature review & clinical update. Arq Bras Cardiol. 2021, 117:1038-44. 10.36660\/abc.20190757","journal-title":"Arq Bras Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.7.8770901","article-title":"Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs","volume":"137","author":"Van Beeren HC","year":"1996","unstructured":"Van Beeren HC, Bakker O, Wiersinga WM. Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs. Endocrinology. 1996, 137:2807-14. 10.1210\/endo.137.7.8770901","journal-title":"Endocrinology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi F","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010, 95:2529-35. 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes SA","year":"2012","unstructured":"Eskes SA, Endert E, Fliers E, Geskus RB, Dullaart RP, Links TP, Wiersinga WM. Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. J Clin Endocrinol Metab. 2012, 97:499-506. 10.1210\/jc.2011-2390","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena L","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018, 7:55-66. 10.1159\/000486957","journal-title":"Eur Thyroid J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS):  The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS):  The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa686","article-title":"Evaluation and treatment of amiodarone-induced thyroid disorders","volume":"106","author":"Ylli D","year":"2021","unstructured":"Ylli D, Wartofsky L, Burman KD. Evaluation and treatment of amiodarone-induced thyroid disorders. J Clin Endocrinol Metab. 2021, 106:226-36. 10.1210\/clinem\/dgaa686","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00259","article-title":"Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience","volume":"2","author":"Kotwal A","year":"2018","unstructured":"Kotwal A, Clark J, Lyden M, McKenzie T, Thompson G, Stan MN. Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience. J Endocr Soc. 2018, 2:1226-35. 10.1210\/js.2018-00259","journal-title":"J Endocr Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88469-a-refractory-case-of-amiodarone-thyrotoxicosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:59Z","timestamp":1707508139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88469-a-refractory-case-of-amiodarone-thyrotoxicosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.28527","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,29]]}}}